A so-called implantable insulin delivery device could one day free people with type 1 diabetes from the need for multiple daily injections, scientists say. "Diabetes is a difficult-to-treat condition, ...

Dr Anne Peters discusses updates in the ADA 2026 Standards of Care in Diabetes, focusing on the use of technology.

“You can think of this as a living medical device that is made from human cells that secrete insulin, along with an electronic life-support system." Reading time 3 minutes MIT scientists might be one ...

The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., June 25, 2025 /PRNewswire/ -- The global Insulin Delivery Device Market, valued at US$32.6 billion ...

In brief: Scientists have spent decades trying to find a cure for type 1 diabetes, an autoimmune condition with no known cause. While reprogramming a human body so it stops attacking the pancreatic ...

Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...

One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections ...

Insulin manufacturers are extending brand-name market exclusivity by filing multiple new patents on their products' delivery devices, a new analysis suggests. The data come from the publicly available ...

Fractyl Health posted new data from its device-based, one-time diabetes treatment, showing its approach not only helped lower average blood sugar but also led to improvements in long-term insulin ...

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to ...